Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marc Pelletier

Thoracic Surgery (Cardiothoracic Vascular Surgery) New Haven, CT Medical Doctor

NPI 1699883207 CMS profile 468619

330 Cedar St Ste 204, New Haven, CT 06510

Open in the dashboard

General payments

$150,582

475 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$558,139 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Marc Pelletier of New Haven, CT is reported in the CMS Open Payments database as having received $150,582 across 475 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $558,139 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,491 33
2024 General $56,652 127
2023 General $21,113 90
2022 General $29,455 95
2021 General $3,528 36
2020 General $10,041 32
2019 General $23,303 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marc Pelletier
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Marc Pelletier were reported at $6,491. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Marc Pelletier Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $23,303 $886 $178–$3,167 $163
2020 $10,041 $341 $108–$1,605 $114
2021 $3,528 $453 $125–$1,886 $132
2022 $29,455 $695 $180–$2,566 $149
2023 $21,113 $745 $205–$2,662 $160
2024 $56,652 $799 $214–$2,967 $164
2025 $6,491 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $62,237 157 payments
  2. Medtronic Vascular, Inc. $25,083 56 payments
  3. Edwards Lifesciences Corporation $24,611 73 payments
  4. Atricure, Inc. $19,207 42 payments
  5. Intuitive Surgical, Inc. $5,544 18 payments
  6. Abbott Laboratories $4,128 45 payments
  7. Ethicon US, LLC $2,926 4 payments
  8. Acutus Medical, Inc. $1,422 1 payment
  9. Bolton Medical Inc $766 5 payments
  10. CryoLife, Inc. $630 6 payments
  11. Other $4,028 68 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $56,560 22 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,160 13 payments
  3. Travel and Lodging $31,380 76 payments
  4. Food and Beverage $24,029 356 payments
  5. Education $2,650 3 payments
  6. Grant $1,288 1 payment
  7. Honoraria $1,200 1 payment
  8. Long term medical supply or device loan $282 1 payment
  9. Entertainment $33 2 payments
Products named General payments · program years 2019–2025
  1. Avalus Heart Valves $25,858 66 payments
  2. Avalus Heart Valves $12,333 14 payments
  3. COREVALVE EVOLUT R $11,923 17 payments
  4. SYNERGY ABLATION SYSTEM $11,232 23 payments
  5. ATRICLIP LAA EXCLUSION SYSTEM $9,746 21 payments
  6. Mosaic $8,941 4 payments
  7. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $8,088 5 payments
  8. CoreValve Evolut $8,064 16 payments
  9. MITRIS RESILIA Mitral Valve $3,440 18 payments
  10. Da Vinci Surgical System $3,044 17 payments
  11. Other $31,308 234 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Cardiac Surgery: 68

Drug cost

$20

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Furosemide Generic 14 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$111,263

Medicare's payments for the services billed

Medicare patients

141

Average age 76

Services billed

250

59 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 55%
Arthritis 52%
Atrial fibrillation 50%
Chronic kidney disease 43%
Diabetes 40%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

475 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record